Your browser doesn't support javascript.
loading
Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.
Gong, Dingxu; Zhang, Yujian; Zhang, Hao; Gu, Haiyong; Jiang, Qin; Hu, Shengshou.
Afiliación
  • Gong D; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center of Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Cardiovasc Toxicol ; 12(4): 350-8, 2012 Dec.
Article en En | MEDLINE | ID: mdl-22814936
Ischemia/reperfusion damage is common during open-heart surgery. Activation of aldehyde dehydrogenase-2 can significantly reduce ischemia/reperfusion damage. We hypothesized that adding aldehyde dehydrogenase-2 agonist to regular cardioplegia solution would further ameliorate ischemia/reperfusion damage. Alda-1 was used as an aldehyde dehydrogenase-2 agonist. Cardioprotection by histidine-tryptophan-ketoglutarate solution with and without Alda-1 was compared using an ex vivo perfused rat heart model of ischemia/reperfusion. Three groups of ex vivo rat hearts endured different treatments with variant ischemia or an ischemia/reperfusion time course: sham, no ischemia/reperfusion; histidine-tryptophan-ketoglutarate; and histidine-tryptophan-ketoglutarate plus Alda-1. Aldehyde dehydrogenase-2 expressions and activities, oxidative parameters (including 4-hydroxy-2-nonenal-His adducts, malondialdehyde levels, and glutathione/oxidized glutathione ratios), myocardial protein carbonyl levels, coronary effluents creatine kinase isoenzyme MB levels, and heart function parameters were measured and compared. Alda-1 significantly elevated myocardium aldehyde dehydrogenase-2 activity (P < .01). Increased aldehyde dehydrogenase-2 activity in turn attenuated ischemia/reperfusion-induced elevation in cardiac aldehydes, creatine kinase isoenzyme MB leakage, and protein carbonyl formation (P < .01). The Alda-1 group also obtained higher glutathione/oxidized glutathione ratios (P < .01). Aldehyde dehydrogenase-2 activation alleviated ischemia/reperfusion-induced cardiomyocyte contractile function impairment as evidenced by improved maximal velocity of pressure development and decline, left ventricular developed pressure, and heart rate (P < .01). Alda-1 supplementation can significantly improve the cardioprotection effect of cardioplegia solution, possibly through activation of aldehyde dehydrogenase-2, to remove toxic aldehydes. This may aid in the identification of novel cardioplegia solutions.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiotónicos / Daño por Reperfusión Miocárdica / Proteínas Mitocondriales / Aldehído Deshidrogenasa / Paro Cardíaco / Paro Cardíaco Inducido Límite: Animals Idioma: En Revista: Cardiovasc Toxicol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TOXICOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiotónicos / Daño por Reperfusión Miocárdica / Proteínas Mitocondriales / Aldehído Deshidrogenasa / Paro Cardíaco / Paro Cardíaco Inducido Límite: Animals Idioma: En Revista: Cardiovasc Toxicol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TOXICOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos